PlainRecalls
FDA Devices Low Class III Terminated

iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HOUR Average Wear Time, 6/1-patch pouches/box. Dosage: 120mA/min.

Reported: January 12, 2022 Initiated: November 10, 2021 #Z-0454-2022

Product Description

iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HOUR Average Wear Time, 6/1-patch pouches/box. Dosage: 120mA/min.

Reason for Recall

The dosage information on the pouch is incorrect; the primary carton label is correct.

Details

Recalling Firm
Tapemark Company
Units Affected
5,141 primary cartons
Distribution
US Nationwide distribution in the states of CA, FL, IL, MO, NY, OH, and TN.
Location
Saint Paul, MN

Frequently Asked Questions

What product was recalled?
iontoPATCH On-the-Go Patch Therapy, Transdermal Iontophoretic Drug Delivery System, Extra Strength, 8-HOUR Average Wear Time, 6/1-patch pouches/box. Dosage: 120mA/min.. Recalled by Tapemark Company. Units affected: 5,141 primary cartons.
Why was this product recalled?
The dosage information on the pouch is incorrect; the primary carton label is correct.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 12, 2022. Severity: Low. Recall number: Z-0454-2022.